Saved in:
| Main Authors: | Choudhury, Shubham, Raghava, Gajendra |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2026
|
| Online Access: | https://doi.org/10.5281/zenodo.19878400 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
A large language model for predicting neurotoxic peptides and neurotoxins
by: Anand Singh Rathore, et al.
Published: (2025)
by: Anand Singh Rathore, et al.
Published: (2025)
MRSLpred: A computational tool for multilabel mRNA subcellular localization prediction
by: Choudhury, Shubham, et al.
Published: (2026)
by: Choudhury, Shubham, et al.
Published: (2026)
AFProPred – Prediction of antifreeze proteins using machine learning and evolutionary information
by: Nishant Kumar, et al.
Published: (2026)
by: Nishant Kumar, et al.
Published: (2026)
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models
by: Alessia Anastasia, et al.
Published: (2025)
by: Alessia Anastasia, et al.
Published: (2025)
Prediction of Anti‐Freezing Proteins From Their Evolutionary Profile
by: Nishant Kumar, et al.
Published: (2024)
by: Nishant Kumar, et al.
Published: (2024)
Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
by: Jacob E. Till, et al.
Published: (2026)
by: Jacob E. Till, et al.
Published: (2026)
Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
by: Susumu Daibo, et al.
Published: (2024)
by: Susumu Daibo, et al.
Published: (2024)
Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
by: Silvana Debernardi, et al.
Published: (2024)
by: Silvana Debernardi, et al.
Published: (2024)
Prediction of Plant Resistance Proteins Using Alignment‐Based and Alignment‐Free Approaches
by: Pushpendra Singh Gahlot, et al.
Published: (2024)
by: Pushpendra Singh Gahlot, et al.
Published: (2024)
Risk factors for suicide in patients with pancreatic ductal adenocarcinoma: A population‐based study
by: Chao Wang, et al.
Published: (2024)
by: Chao Wang, et al.
Published: (2024)
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
by: Andrea Vallés‐Martí, et al.
Published: (2024)
by: Andrea Vallés‐Martí, et al.
Published: (2024)
Comparative spatial transcriptomics of pancreatic cancer with ductal and acinar origins in mouse models
by: Ming Cui, et al.
Published: (2025)
by: Ming Cui, et al.
Published: (2025)
Real‐world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
by: Toshifumi Doi, et al.
Published: (2024)
by: Toshifumi Doi, et al.
Published: (2024)
Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma
by: Deema Sabtan, et al.
Published: (2026)
by: Deema Sabtan, et al.
Published: (2026)
Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways.
by: Khine, Hnin Ei Ei, et al.
Published: (2025)
by: Khine, Hnin Ei Ei, et al.
Published: (2025)
The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma
by: Parisa Oviedo, et al.
Published: (2024)
by: Parisa Oviedo, et al.
Published: (2024)
The inverted U‐shaped relationship between epinephrine and pancreatic ductal adenocarcinoma patients' survival with compensation of lymphocyte
by: Bing‐Xue Li, et al.
Published: (2024)
by: Bing‐Xue Li, et al.
Published: (2024)
Hemolytik 2: An Updated Database of Hemolytic Peptides and Proteins
by: Rathore, Anand Singh, et al.
Published: (2026)
by: Rathore, Anand Singh, et al.
Published: (2026)
Integration of dual‐energy CT characteristics and biomarkers: Noninvasive prediction of Ki‐67 expression in pancreatic ductal adenocarcinoma
by: Wuyang Zhang, et al.
Published: (2026)
by: Wuyang Zhang, et al.
Published: (2026)
Whole‐transcriptome sequencing analyses identified exosomal circular RNAs in the plasma of pancreatic cancer patients as novel blood‐based biomarkers of disease
by: Xiaomeng He, et al.
Published: (2026)
by: Xiaomeng He, et al.
Published: (2026)
Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
by: Hitomi Nakamura, et al.
Published: (2024)
by: Hitomi Nakamura, et al.
Published: (2024)
PRRpred: A Hybrid Model for Predicting Pattern Recognition Receptors Using Evolutionary Information
by: Kaur, Dilraj, et al.
Published: (2020)
by: Kaur, Dilraj, et al.
Published: (2020)
Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
by: Hannah Mearns, et al.
Published: (2026)
by: Hannah Mearns, et al.
Published: (2026)
Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation
by: Elena Genova, et al.
Published: (2026)
by: Elena Genova, et al.
Published: (2026)
Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach
by: Marc Hilmi, et al.
Published: (2025)
by: Marc Hilmi, et al.
Published: (2025)
ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma
by: Yifeng Sun, et al.
Published: (2024)
by: Yifeng Sun, et al.
Published: (2024)
Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells
by: Demet Kaçaroğlu, et al.
Published: (2024)
by: Demet Kaçaroğlu, et al.
Published: (2024)
CBTOPE2: An improved method for predicting of conformational B-cell epitopes in an antigen from its primary sequence
by: Pandey, Anupma, et al.
Published: (2025)
by: Pandey, Anupma, et al.
Published: (2025)
HAIRpred : Prediction of human antibody interacting residues in an antigen from its primary structure
by: Ruchir Sahni, et al.
Published: (2025)
by: Ruchir Sahni, et al.
Published: (2025)
Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
by: Junki Fukuda, et al.
Published: (2024)
by: Junki Fukuda, et al.
Published: (2024)
Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts
by: Ting Zhang, et al.
Published: (2025)
by: Ting Zhang, et al.
Published: (2025)
Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
by: Qun Chen, et al.
Published: (2024)
by: Qun Chen, et al.
Published: (2024)
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
by: Yecheng Li, et al.
Published: (2024)
by: Yecheng Li, et al.
Published: (2024)
Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression
by: Yingying Tong, et al.
Published: (2024)
by: Yingying Tong, et al.
Published: (2024)
Minimally invasive determination of pancreatic ductal adenocarcinoma ( PDAC ) subtype by means of circulating cell‐free RNA
by: Martin Metzenmacher, et al.
Published: (2024)
by: Martin Metzenmacher, et al.
Published: (2024)
Clinicopathological predictive factors in long‐term survivors who underwent surgery for pancreatic ductal adenocarcinoma: A single‐center propensity score matched analysis
by: Carlo Ingaldi, et al.
Published: (2024)
by: Carlo Ingaldi, et al.
Published: (2024)
Inhibition of PHF1 promotes ferroptosis via IRES‐dependent Snail translation regulation in pancreatic ductal adenocarcinoma
by: Yujiao Xie, et al.
Published: (2026)
by: Yujiao Xie, et al.
Published: (2026)
Evaluation of fine‐needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features
by: Raul S Gonzalez, et al.
Published: (2024)
by: Raul S Gonzalez, et al.
Published: (2024)
Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma
by: Huarui Cai, et al.
Published: (2024)
by: Huarui Cai, et al.
Published: (2024)
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells
by: Maria Poles, et al.
Published: (2025)
by: Maria Poles, et al.
Published: (2025)
Similar Items
-
A large language model for predicting neurotoxic peptides and neurotoxins
by: Anand Singh Rathore, et al.
Published: (2025) -
MRSLpred: A computational tool for multilabel mRNA subcellular localization prediction
by: Choudhury, Shubham, et al.
Published: (2026) -
AFProPred – Prediction of antifreeze proteins using machine learning and evolutionary information
by: Nishant Kumar, et al.
Published: (2026) -
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models
by: Alessia Anastasia, et al.
Published: (2025) -
Prediction of Anti‐Freezing Proteins From Their Evolutionary Profile
by: Nishant Kumar, et al.
Published: (2024)